secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001829126-23-004464
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organicell appoints Howard Golub as EVP/CSO; 30+ years in clinical therapeutics
-------------------------------------------------------------------------------

- Howard L. Golub, MD, PhD appointed EVP and Chief Science Officer effective June 29, 2023.
- Dr. Golub brings over 30 years of clinical research experience, including VP R&D at Walgreens Boots Alliance and founding CareStat LLC.
- He will lead Organicell's R&D for innovative regenerative biologic therapies.
- CEO Harry Leider stated the appointment strengthens the company's research leadership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912623004464/0001829126-23-004464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912623004464/organicellrege_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-23-004464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer